Skip to content

Comparative study on bowel nosodes and individualised Homoeopathic medicine in treatment of Irritable Bowel Syndrome

TO COMPARE THE EFFICACY OF BOWEL NOSODES WITH INIVIDUALISED HOMOEOPATHIC MEDICINES IN TREATMENT OF IRRITABLE BOWEL SYNDROME -SINGLE BLIND, COMPARATIVE RANDOMIZED CONTROLLED TRIAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103650
Enrollment
60
Registered
2026-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Bowel nosodes: Bowel nosodes are given as per homoeopathic principles in different potencies. Follow up is taken after every 15 days. Calibration of scale is( Ibs-Qol and Ibs -sss ) i

Sponsors

Dr Priyavani Panwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient fulfilling the ROME III criteria. 2 Patient who has a score of zero to 299 in IBS-SSS Score. 3 Patient of both sexes, all religion and socioeconomic status.

Exclusion criteria

Exclusion criteria: 1 Patients who had prior abdominal surgery which may cause bowel symptoms similar to IBS. 2 Patients with evidence of abnormal laboratory or imaging findings inconsistent with IBS. 3 Patients presenting with unintentional weight loss, rectal bleeding, family history of colorectal cancer onset at older age. 4 Currently participating in another trial studies.Patients with uncontrolled co-morbidites (hypertension, diabetes mellitus and hyperthyroidism) . 5 Pregnant females, lactating mothers and women who are planning for pregnancy in near future. 6 Patients who are not willing to participate in the study and currently participating in another trial studies. 7 Current use of long-term systemic steroids, immunosuppressants, or other therapies likely to interfere with the assessment of homoeopathic treatment outcomes.

Design outcomes

Primary

MeasureTime frame
At the end of the study, it is expected in improvement of IBS-SSS. This measure overall symptoms reduction or relief as the main indicators of treatment efficacy.Timepoint: 6 months

Secondary

MeasureTime frame
The improvement of patient quality of life is measured by Ibs-Qol questionnaire.Timepoint: 6 months

Countries

India

Contacts

Public ContactPriyavani Panwar

National homoeopathic medical college , Lucknow

rhreshma@gmail.com9473854481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026